Search: 13th AM Faculty
Results 1 - 20 of 92

Lisa Baker

Medical Writer

Type of Company:
Professional Degrees: CMPP, PhD
CMPP Certified: (3/2017)

Bio: Lisa Baker, PhD, CMPP, is an experienced publications professional who previously worked full-time at leading agencies including inScience Communications, Springer Healthcare (Medical Director, 2015-17) and Envision Pharma Group (Principal Medical Writer/Team Lead, 2010-2015). Lisa is now a freelance medical writer developing publications, strategic publication deliverables and educational materials for pharmaceutical and medical communications clients.

Patricia Baskin

Neurology Journals

Bio: Patricia (Patty) Baskin, MS, is Executive Editor of the four Neurology journals. She worked in genetics research before assuming positions of Executive Managing Editor, Manager of Program Operations, and Managing Editor at various bioscience journals. She is currently President of the Council of Science Editors and previously served as Editor-in-Chief of Science Editor, has served as faculty for several CSE short courses (publication management, publication ethics, electronic publication), and established the CSE publication ethics course and an editors' course (in Brazil). She has developed numerous seminars and workshops on publication metrics, ethics and misconduct, authorship criteria, ghostwriting, conflict of interest, Web design, open access, and other topics common to publication professionals. She manages a team of 12 people who create the weekly Neurology journal plus three bi-monthly spin-off journals, two mini-sites, a Resident & Fellow site, a weekly podcast, a weekly press release, a journal CME program, and a Patient Page site.

Chris Baumle


Bio: Chris Baumle is Executive Publisher, Health and Medical Sciences, Elsevier. Chris's career in medical publishing spans over 30 years. He currently manages a portfolio of journals in specialties including pharmacy and pharmaceutical sciences, rehabilitation, infection control, and allied health. Chris is a graduate of Stockton University and lives in southern New Jersey with his family and two cats.

Yukti Bharwani

Associate Director, Operations, Medical Communications
Cactus Communications Pvt. Ltd.

Type of Company:
Communications Agency
Professional Degrees: ELS

Bio: Yukti has over 8 years of experience in the scientific communications industry-first as a science editor herself and later managing operations for a large editorial and publication support team at Editage, a division of Cactus Communications. During her tenure at Editage, Yukti interacted with researchers from the Asia-Pacific region. She was instrumental in developing targeted solutions for difficulties faced by ESL authors in the publication process. Her efforts have ranged from developing publication strategies for authors at various stages of their academic career to guiding her team of science editors and writers to consistently offer high-value publication services such as manuscript rewriting, journal recommendation, and scientific illustration services. A firm believer in creating awareness of ethical publication practices, Yukti has conducted a number of workshops on issues relevant to the journal publication process, including one on Navigating the Publication Process and Common Editorial Mistakes at the 36th Annual Meeting of the Molecular Biology Society of Japan in December 2013. Yukti has a Master's degree in Environmental Science and an ELS certification from the Board of Editors in the Life Sciences (BELS).

Angela Bickford

Director, Publications & Disclosure Practices, R&D, Chief Medical Officer

Type of Company:
Professional Degrees: BA/BS, MS, PhD
CMPP Certified: 3/2015

Bio: Angela is the R&D Publication Lead in the Publications ¿ Disclosure Practices¿ group at GSK. She has 17 years of experience working in a global publication role including employment at Eli Lilly & Co and Novartis. She has been with GSK nine years. Her current responsibilities include oversight of publication planning and development in R&D. She also manages direct reports, leads global publication teams in the Neuroscience therapeutic area and develops training materials for internal employees. She has been a member of the ISMPP Board of Trustees since 2015.

Liz Bilodeau

Copyright Clearance Center

Bio: Liz Bilodeau is a Senior Client Engagement Manager at Copyright Clearance Center (CCC). CCC is a global leader in content management, discovery and document delivery solutions. Through its relationships with those who use and create content, CCC drives market-based solutions that accelerate knowledge, power publishing and advance copyright. With its subsidiaries RightsDirect and Ixxus, CCC provides solutions for millions of people from the world's largest companies and academic institutions. Liz has developed a deep appreciation of the concerns and needs of content users worldwide since joining CCC in 2005. She spends much of her time helping Corporate clients with their Annual Copyright License, Motion Picture License, Music Use License and RightFind Software. She is focused on ensuring clients understand the boundaries of their license, assisting with permissions and educating clients on the basics of copyright.

Jessica Bowler

Associate Director, Procurement
Pfizer Inc.

Type of Company:
Professional Degrees: MBA

Bio: Jessica Bowler is currently an Associate Director on the Agency Team within Global Procurement at Pfizer Inc. overseeing the Global Medical Education and Publication Categories. Jessica joined Pfizer in January 2002 and during her career at Pfizer has supported Clinical Trials as a Study Manager and worked on other Indirect Categories in Procurement including but not limited to: QA, Safety and Medical Information. Prior to joining Pfizer, Jessica worked at Organon and Memorial Sloan Kettering Cancer Center. Jessica has a BA in Health and Society from University of Rochester and an MBA in Health Care Administration from Baruch College and Mt. Sinai School of Medicine.

Tracy Bunting-Early

Publication Lead, USMA

Type of Company:
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (3/2011)

Bio: Tracy Bunting-Early is a Global Publications Leader at AstraZeneca Pharmaceuticals, where she has overseen oncology, immunology, hematology, and infectious disease related publications. She began her career in pharmaceutical advertising after obtaining her PhD in molecular biology from Rutgers University. Prior to working at AstraZeneca, Tracy led a boutique medical communications company for over 15 years providing content more than 200 projects for over 50 manufacturers supporting medical content across medical affairs, commercial, and medical education. She is also the founder and CEO of Outcomes Positive, a not-for- profit, think-tank leading a medical advisory board in research and development of educational materials to improve diagnosis of kidney infections in very young children, which affect over 400,000 children in the US each year. She lives in Landenberg, PA with her husband and her daughter.

Gary Burd

SVP, Global Medical Director

Type of Company:
Communications Agency
Professional Degrees: BA/BS, MA, PhD
CMPP Certified: (3/2017)

Bio: Gary has 13 years of medical communications and scientific publishing experience. He joined McCann Complete Medical in 2006, and is now SVP, Global Medical Director for Caudex, based in their New York office. Gary has led communication planning and publication planning activities in several therapy areas and has collaborated with teams in many European and US pharmaceutical companies, including Bayer Schering, Roche, Lundbeck, Novartis, Novo Nordisk, Boehringer Ingelheim, GSK, AstraZeneca, BMS, Merck Serono, EMD Serono, Pfizer, and, more recently, Japanese pharmaceutical companies Chugai and Mitsubishi Tanabe. Prior to his medical communications career he gained valuable editorial experience in journal publishing with Portland Press. Gary obtained his PhD from the Kennedy Institute of Rheumatology, London working on a monoclonal antibody therapy for systemic lupus erythematosus.

Alice Choi

Global Head
Complete Medical Communications

Type of Company:
Communications Agency
Professional Degrees: BA/BS, CMPP, MPH, MS, PhD
CMPP Certified: (3/2011)

Bio: Alice Choi is currently the Global Head of Complete Medical Communications (CMC), a division of McCann Complete Medical. Alice has an honours degree in Pharmacology, a Masters Degree in Clinical Pharmacology, a Masters in Public Health and a doctorate in cancer epidemiology. Pre CMC, Alice began her career in academia as a researcher before moving on to a number of healthcare agencies, working in medical communications, market research and health outcomes. Since joining CMC in 2002, Alice has held a number of different roles, including account director and commercial director, before taking up her current position in 2006. In this role, she oversees a multidisciplinary team based in offices across the UK and the US. Alongside her broader operational responsibilities, Alice continues to work closely with several clients. Having 20+ years of experience in a range of different therapy areas, she assists clients with a variety of projects including communication planning, Phase IIIB/IV planning, stakeholder services and general consultancy - in particular, publication planning and best practice scientific exchange are important areas for Alice and the wider CMC team. Alice is a Certified Medical Publication Professional and has contributed to several ISMPP committees over the years. She currently serves on the Advocacy and Outreach Committee, is a Past Chair of the Board of Trustees for ISMPP and was the Chair of the 2016 Annual Program Committee. She also serves as a Governor for The Christie NHS Foundation Trust, one of Europe's leading cancer centres.

Juli Clark

Director, Global Medical Writing, Global Publications

Type of Company:
Professional Degrees: PharmD

Bio: Juli has directed the Global Medical Writing department at Amgen for 10 years, and has 20 years of experience in the biotech industry, having managed staff and services in Medical Writing, Medical Information and Medical Communication roles. Prior to joining Amgen, she worked for two smaller companies (Pathogenesis, and Otsuka). Juli earned her B.S. Pharmacy and Doctor of Pharmacy degrees at University of Iowa, completing a General Hospital Pharmacy Residency program, and a Fellowship in Ambulatory Care Clinical Pharmacy. Before entering the biotech/pharma industry, Juli practiced as a clinical pharmacy specialist in a variety of settings including managed care, Indian Health Service, private and large University Hospitals. Juli was Vice-Chair of the 12th Annual Meeting of ISMPP and will be assuming the role of Chair, ISMPP Board of Trustees at the end of the 13th Annual Meeting. She has been an active participant/presenter in the Medical Publishing Insights and Practices Initiative (MPIP) as well as with ISMPP, AMWA and DIA.

Rhonda Croxton

Sr Vice President, Clinical Content & Editorial Services
CHC Group

Type of Company:
Communications Agency
Professional Degrees: BA/BS, PhD

Bio: Rhonda has worked in the medical communications industry for the past 13+ years, with both agency and pharmaceutical industry experience in her background. After earning her PhD and completing a 2-year postdoc in oncology research, she began her medical communications career as a Medical Writer with Trinity Communications, Inc, and later grew into the role of Medical Director during her first tenure with Complete Healthcare Communications (CHC), Inc. During those 4 years of medical communications agency experience, she acquired a solid foundation in publication planning and content development across a variety of therapeutic areas and types of deliverable. After honing her skills on the agency side of the industry, she joined AstraZeneca as a Clinical Publications Lead to experience medical communications from the pharmaceutical industry perspective. Currently, as Sr VP of Clinical Content & Editorial Services with CHC Group, Rhonda oversees a team of 30+ Scientific Directors, Medical Writers, and Medical Editors and is responsible for ensuring client satisfaction with editorial quality, efficient resourcing of scientific/editorial staff to manage workloads, and adherence to the highest ethical standards for medical communications in the industry. Rhonda served as a member of the ISMPP Standards Committee in 2014 and contributed to the development of GPP3 as a reviewer of the draft version of the document. Rhonda is a strong advocate for the vision and mission of ISMPP and has been a member since its inception in 2005.

Elvira D'souza

President, Global Medical Communications, Medical Communications
Cactus Communications

Type of Company:
Communications Agency
Professional Degrees: CMPP
CMPP Certified: (9/2011)

Bio: Elvira D'souza has over 10 years of experience in the medical communications industry. Elvira has a very good understanding of the logistics of global outsourcing of medical writing services and works extensively with key decision makers within pharmaceutical/device companies globally to develop long-term relationships and provide solutions for assistance with multiple types of projects including publication planning, graphics support, regulatory writing, and marketing support documentation across a range of therapeutic areas. During her tenure at CACTUS, Elvira has also gained expertise in interacting with individual authors/researchers from all over the globe, especially in the Asia-Pacific region. Elvira helped conduct the first BELS exam in India and has also proctored subsequent BELS exams in the country. She has a Bachelor's degree in life sciences from the University of Mumbai and a master's in business administration from Narsee Monjee Institute of Management Studies in Mumbai, India. She also has an ELS certification from the Board of Editors in the Life Sciences and is a certified medical publication professional.

Ann Davis

Senior Manager, Medical Communications
Strongbridge BioPharma

Type of Company:
Professional Degrees: CMPP, MPH
CMPP Certified: (3/2012)

Bio: Ann Davis is Senior Manager of Medical Communications at Strongbridge BioPharma, where she manages development and execution of publication plans, as well as medical communications platforms, for rare disease assets. Ann has more than 25 years of experience in the medical communications field, including content development roles at Centocor Ortho Biotech (now Janssen Pharmaceuticals) and Bristol-Myers Squibb. At BMS, she also served as a Global Publication Advisor, developing publications policies and practices, as well as advising and training internal stakeholders and agency partners. An ISMPP-certified medical publication professional, she has served as workshop leader for ISMPP and the American Medical Writers Association, author of multiple ISMPP poster presentations, and a member of various ISMPP committees. She has been an invited speaker at TIPPA and other publication planning seminars, Ann completed her graduate studies at the University of Texas Houston Health Science Center.

Kay Dickersin

Bloomberg School of Public Health, Johns Hopkins

Bio: Kay Dickersin, M.A., Ph. D. is Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where she serves as the Director for the Center for Clinical Trials and Evidence Synthesis. She is also Director of the U.S. Cochrane Center. Kay's main research contributions have been in the area of scientific integrity, reporting biases, trials registration, clinical trials, systematic reviews and meta-analysis. Kay's research has involved comparing internal company documents to the published record, where she and her colleagues have found differing results. She is currently engaged in examining practical issues related to demands for "open access to trial data," when the available data may be discordant.

Tania Dickson

Team Lead
ProScribe - Envision Pharma Group

Type of Company:
Communications Agency
Professional Degrees: BA/BS, PhD
CMPP Certified: (3/2017)

Bio: Tania Dickson received her Doctorate in prostate cancer from the Institute of Reproduction and Development at Monash University in Melbourne Australia, where she evaluated the role of the TGF-beta superfamily on normal and neoplastic growth of the prostate. She completed her postdoctoral fellowship at the Ingram Cancer Center at Vanderbilt University in Nashville Tennessee USA. After her fellowship, Tania joined Merck and Co, Inc in Blue Bell Pennsylvania as a Senior Medical writer supporting the cardiovascular clinical group. During her tenure at Merck, Tania contributed to more than 15 peer reviewed manuscripts, of which she is an author of eight. Tania left Merck to join Elsevier where she was a medical director for Carus Clinical Communications an Elsevier Business and subsequently was promoted to Vice President of the Elsevier Office of Continuing Medical Education. Tania joined ProScribe in December 2013 and has over 15 years of experience in medical communications. She has written abstracts, posters, manuscripts, slide kits, and content for advisory boards on a wide range of topics in various therapeutic areas.

Riad Dirani

Teva Pharmaceuticals

Bio: Riad Dirani, PhD, is currently the VP of Global Health Economic and Outcomes Research at Teva Pharmaceuticals. His responsibilities include overseeing the establishment of this function within Medical Affairs, and developing the strategic capabilities for HEOR to optimize the development and commercialization of Teva¿s portfolio of products and offerings globally. Riad has worked in the pharmaceutical industry since 2000, including positions of increasing responsibility at Aventis, GlaxoSmithKline, Pfizer, and Johnson & Johnson in multiple therapeutic areas. Riad joined Teva in 2014 to build the HEOR group and establish it operating model. Riad received his Ph.D. in Health Services Research/Health Economics from The Pennsylvania State University. He has published over 25 journal articles and made numerous presentations to professional organizations, including the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and therapeutic-specific conferences.

Jonathan Druhan

Global Publications Director, CVMD, Global Medical Affairs
AstraZeneca Pharmaceuticals

Type of Company:
Professional Degrees: BA/BS, MA, PhD

Bio: Jon Druhan is a Global Publications Director, CVMD at AstraZeneca Pharmaceuticals LP. His background includes a BSc from McGill University, MA and PhD degrees in Biopsychology from the University of British Columbia in Vancouver, Canada, and more than 25 years of scientific communications work in both academic and industry settings. Earlier in his career, Jon held successive tenure-track faculty positions in Psychiatry Departments at MCP-Hahnemann University and the University of Pennsylvania. Jon subsequently went on to pursue opportunities in the Medical Communications field, initially working as a medical writer at Trinity Communications and Scientific Connexions, and then working as Assistant/Associate Director of Publications at Johnson & Johnson. He joined AstraZeneca in March of 2006, and managed their US-based publications professionals for over 5 years. During this time, Jon served as Chair of the Ethics Committee for the International Society for Medical Publications Professionals (ISMPP) and he frequently presented on issues related to publications ethics and best practices at ISMPP meetings and Center for Business Intelligence forums on Publication Planning. In 2011, he took on the role of Medical Scientific Compliance Director, providing policy and compliance support to AstraZeneca's US Medical Affairs department. During his three years as Compliance Director, Jon developed broad expertise in policy and regulatory issues related to scientific exchange and medical communications. He returned to the field of Medical Publications as US Publications Director for AstraZeneca in October 2014 and then assumed his current role as Global Publications Director, CVMD at the start of 2016.

Marion Enie

Envision Pharma Group

Bio: Marion has been with Envision since 2006 assuming increasing responsibilities and leading teams across multiple accounts and therapeutic areas. Marion currently leads Operational Excellence Solutions where she leverages her broad industry expertise specializing in medical affairs operational support including policy and compliance tools and processes, change management evaluation, implementation and continuous improvement. Marion began her career with as clinical medical technologist with a specialty in hematology. She left the clinical world to take a position with Boehringer Mannheim Diagnostics (now Roche) in the development and marketing of medical devices. Through an interest in product development, Marion accepted an appointment at Indiana University as Manager of Technology Transfer where she collaborated between the University and industry to help commercialize the University's intellectual property. Marion then returned to industry spending 7 years at Eli Lilly and Company, where she supported the launch of multiple products in diabetes and CNS. She was also part of a task force that initiated scientific data disclosure strategy in order to improve and standardize policies and processes to support the communication of scientific evidence. Marion is active in the International Society of Medical Publications Professionals (ISMPP) and has served on the Annual Meeting Workshop Committee from 2009-2011. Marion received her BS degree in Biology from California State University, California, PA and a Certificate in Industrial Chemistry and Business Management from Chatham College, Pittsburgh, PA.

Brian Falcone

Executive Vice President
Oxford PharmaGenesis

Type of Company:
Communications Agency
Professional Degrees: BA/BS, MA, PhD

Bio: Brian Falcone, PhD, is the Executive Vice President of Oxford PharmaGenesis, Inc., which is the US arm of Oxford PharmaGenesis Ltd. Since joining the company in 2013, Brian has been deeply involved with the strategic and tactical planning of publications for a range of new and established products, including those in which patient engagement and involvement are critical for success of the brands. Activities involving patients have included patient advisory boards, patient-written publications, lay summaries of clinical trials, and educational materials. Brian has over 12 years of experience in medical communications, working on a range of services, including scientific narrative and platform development, rigorous thought-leader engagement activities, and non-traditional, bespoke solutions to specific communications challenges. Prior to his career in medical communications, Brian received his PhD in organic chemistry from Princeton University, Princeton, NJ, followed by careers as both a professor of chemistry at The College of New Jersey, Ewing, NJ, and a research fellow for Johnson & Johnson Pharmaceutical Research and Development, Spring House, PA.
<< first < Prev 1 2 3 4 5 Next > last >>